{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:20:05Z","timestamp":1794435605815,"version":"4.9.1"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The cGAS-STING pathway is crucial for recognizing aberrant DNA in the cytoplasm and activating the innate immune response. After detecting aberrant DNA in the cytoplasm, cGAS can catalyze the synthesis of cGAMP from ATP and GTP, which acts as a second messenger to engage STING and unleash type I interferons, thereby eliciting a robust antitumor immune cascade. In recent years, the role of the cGAS-STING pathway in tumor immunity has attracted widespread attention. Paradoxically, it not only activates antitumor immune responses but also promotes tumor progression under certain circumstances. This review untangles the safeguards that prevent cGAS from recognizing nuclear self-DNA, delineates the antitumor and pro-tumor mechanisms of the cGAS-STING axis, and surveys tumor immunotherapy strategies targeting this pathway.<\/jats:p>","DOI":"10.1038\/s41419-026-08607-2","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:55:53Z","timestamp":1774428953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The cGAS-STING pathway in cancer: friend or foe"],"prefix":"10.1038","volume":"17","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-0565","authenticated-orcid":false,"given":"Zhaoyang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-8173","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2641-5434","authenticated-orcid":false,"given":"Bo","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-2909","authenticated-orcid":false,"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"8607_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2015.8","volume":"16","author":"X Cao","year":"2016","unstructured":"Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol. 2016;16:35\u201350.","journal-title":"Nat Rev Immunol"},{"key":"8607_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004;5:730\u20137.","journal-title":"Nat Immunol"},{"key":"8607_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455:674\u20138.","journal-title":"Nature"},{"key":"8607_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786\u201391.","journal-title":"Science"},{"key":"8607_CR5","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339:826\u201330.","journal-title":"Science"},{"key":"8607_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2019.01.049","volume":"176","author":"KC Barnett","year":"2019","unstructured":"Barnett KC, Coronas-Serna JM, Zhou W, Ernandes MJ, Cao A, Kranzusch PJ, et al. Phosphoinositide interactions position cGAS at the plasma membrane to ensure efficient distinction between self- and viral DNA. Cell. 2019;176:1432.","journal-title":"Cell"},{"key":"8607_CR7","doi-asserted-by":"publisher","first-page":"E1773","DOI":"10.1073\/pnas.1424637112","volume":"112","author":"MH Orzalli","year":"2015","unstructured":"Orzalli MH, Broekema NM, Diner BA, Hancks DC, Elde NC, Cristea IM, et al. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc Natl Acad Sci USA. 2015;112:E1773\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR8","doi-asserted-by":"publisher","first-page":"E4612","DOI":"10.1073\/pnas.1705499114","volume":"114","author":"H Yang","year":"2017","unstructured":"Yang H, Wang H, Ren J, Chen Q, Chen ZJ. cGAS is essential for cellular senescence. Proc Natl Acad Sci USA. 2017;114:E4612\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1126\/science.abd0609","volume":"370","author":"JA Boyer","year":"2020","unstructured":"Boyer JA, Spangler CJ, Strauss JD, Cesmat AP, Liu P, McGinty RK, et al. Structural basis of nucleosome-dependent cGAS inhibition. Science. 2020;370:450\u20134.","journal-title":"Science"},{"key":"8607_CR10","doi-asserted-by":"publisher","first-page":"e47491","DOI":"10.7554\/eLife.47491","volume":"8","author":"HE Volkman","year":"2019","unstructured":"Volkman HE, Cambier S, Gray EE, Stetson DB. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. Elife. 2019;8:e47491.","journal-title":"Elife"},{"key":"8607_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature23890","volume":"549","author":"L Andreeva","year":"2017","unstructured":"Andreeva L, Hiller B, Kostrewa D, L\u00e4ssig C, De Oliveira Mann CC, Jan Drexler D, et al. cGAS senses long and HMGB\/TFAM-bound U-turn DNA by forming protein\u2013DNA ladders. Nature. 2017;549:394\u20138.","journal-title":"Nature"},{"key":"8607_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2018.06.026","volume":"174","author":"W Zhou","year":"2018","unstructured":"Zhou W, Whiteley AT, de Oliveira Mann CC, Morehouse BR, Nowak RP, Fischer ES, et al. Structure of the human cGAS-DNA complex reveals enhanced control of immune surveillance. Cell. 2018;174:300\u201311.e11.","journal-title":"Cell"},{"key":"8607_CR13","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.3390\/ijms21217842","volume":"21","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li S. Role of post-translational modifications of cGAS in innate immunity. Int J Mol Sci. 2020;21:7842.","journal-title":"Int J Mol Sci"},{"key":"8607_CR14","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.15252\/embj.201488726","volume":"33","author":"AK Mankan","year":"2014","unstructured":"Mankan AK, Schmidt T, Chauhan D, Goldeck M, H\u00f6ning K, Gaidt M, et al. Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. EMBO J. 2014;33:2937\u201346.","journal-title":"EMBO J"},{"key":"8607_CR15","doi-asserted-by":"publisher","first-page":"94142","DOI":"10.1172\/jci.insight.94142","volume":"3","author":"WO Hahn","year":"2018","unstructured":"Hahn WO, Butler NS, Lindner SE, Akilesh HM, Sather DN, Kappe SH, et al. cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses. JCI Insight. 2018;3:94142.","journal-title":"JCI Insight"},{"key":"8607_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature10429","volume":"478","author":"DL Burdette","year":"2011","unstructured":"Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478:515\u20138.","journal-title":"Nature"},{"key":"8607_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, R\u00f6hl I, et al. cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498:380\u20134.","journal-title":"Nature"},{"key":"8607_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","volume":"153","author":"P Gao","year":"2013","unstructured":"Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, et al. Cyclic [G(2\u2032,5\u2032)pA(3\u2032,5\u2032)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 2013;153:1094\u2013107.","journal-title":"Cell"},{"key":"8607_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013;51:226\u201335.","journal-title":"Mol Cell"},{"key":"8607_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature12640","volume":"503","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature. 2013;503:530\u20134.","journal-title":"Nature"},{"key":"8607_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11932","volume":"7","author":"K Mukai","year":"2016","unstructured":"Mukai K, Konno H, Akiba T, Uemura T, Waguri S, Kobayashi T, et al. Activation of STING requires palmitoylation at the Golgi. Nat Commun. 2016;7:11932.","journal-title":"Nat Commun"},{"key":"8607_CR22","doi-asserted-by":"publisher","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","volume":"5","author":"Y Tanaka","year":"2012","unstructured":"Tanaka Y, Chen ZJ. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal. 2012;5:ra20.","journal-title":"Sci Signal"},{"key":"8607_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347:aaa2630.","journal-title":"Science"},{"key":"8607_CR24","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201797858","volume":"37","author":"T Prabakaran","year":"2018","unstructured":"Prabakaran T, Bodda C, Krapp C, Zhang B-C, Christensen MH, Sun C, et al. Attenuation of cGAS-STING signaling is mediated by a p62\/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J. 2018;37:e97858.","journal-title":"EMBO J"},{"key":"8607_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","volume":"155","author":"H Konno","year":"2013","unstructured":"Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155:688\u201398.","journal-title":"Cell"},{"key":"8607_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh0496","volume":"8","author":"X Li","year":"2022","unstructured":"Li X, Yu Z, Fang Q, Yang M, Huang J, Li Z, et al. The transmembrane endoplasmic reticulum-associated E3 ubiquitin ligase TRIM13 restrains the pathogenic-DNA-triggered inflammatory response. Sci Adv. 2022;8:eabh0496.","journal-title":"Sci Adv"},{"key":"8607_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357528","volume":"24","author":"B Yang","year":"2023","unstructured":"Yang B, Pei J, Lu C, Wang Y, Shen M, Qin X, et al. RNF144A promotes antiviral responses by modulating STING ubiquitination. EMBO Rep. 2023;24:e57528.","journal-title":"EMBO Rep"},{"key":"8607_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah7119","volume":"2","author":"G Ni","year":"2017","unstructured":"Ni G, Konno H, Barber GN. Ubiquitination of STING at lysine 224 controls IRF3 activation. Sci Immunol. 2017;2:eaah7119.","journal-title":"Sci Immunol"},{"key":"8607_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10680","volume":"7","author":"CK Holm","year":"2016","unstructured":"Holm CK, Rahbek SH, Gad HH, Bak RO, Jakobsen MR, Jiang Z, et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nat Commun. 2016;7:10680.","journal-title":"Nat Commun"},{"key":"8607_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","volume":"71","author":"G Dunphy","year":"2018","unstructured":"Dunphy G, Flannery SM, Almine JF, Connolly DJ, Paulus C, J\u00f8nsson KL, et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-\u03baB signaling after nuclear DNA damage. Mol Cell. 2018;71:745\u201360.e5.","journal-title":"Mol Cell"},{"key":"8607_CR31","doi-asserted-by":"publisher","first-page":"E2058","DOI":"10.1073\/pnas.1716937115","volume":"115","author":"KM Franz","year":"2018","unstructured":"Franz KM, Neidermyer WJ, Tan Y-J, Whelan SPJ, Kagan JC. STING-dependent translation inhibition restricts RNA virus replication. Proc Natl Acad Sci USA. 2018;115:E2058\u201367.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8657","volume":"363","author":"A Ablasser","year":"2019","unstructured":"Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019;363:eaat8657.","journal-title":"Science"},{"key":"8607_CR33","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","volume":"11","author":"M Jiang","year":"2021","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, et al. Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021;11:2983\u201394.","journal-title":"Acta Pharm Sin B"},{"key":"8607_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179\u2013204.","journal-title":"Mol Cell"},{"key":"8607_CR35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071\u20138.","journal-title":"Nature"},{"key":"8607_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hep.32335","volume":"77","author":"H Ma","year":"2023","unstructured":"Ma H, Kang Z, Foo TK, Shen Z, Xia B. Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway. Hepatology. 2023;77:33\u201347.","journal-title":"Hepatology"},{"key":"8607_CR37","doi-asserted-by":"publisher","first-page":"djw199","DOI":"10.1093\/jnci\/djw199","volume":"109","author":"EE Parkes","year":"2017","unstructured":"Parkes EE, Walker SM, Taggart LE, McCabe N, Knight LA, Wilkinson R, et al. Activation of STING-dependent innate immune signaling by S-phase-specific DNA damage in breast cancer. J Natl Cancer Inst. 2017;109:djw199.","journal-title":"J Natl Cancer Inst"},{"key":"8607_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139333","volume":"131","author":"M Hu","year":"2021","unstructured":"Hu M, Zhou M, Bao X, Pan D, Jiao M, Liu X, et al. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. J Clin Invest. 2021;131:e139333.","journal-title":"J Clin Invest"},{"key":"8607_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-018-0629-6","volume":"563","author":"H Liu","year":"2018","unstructured":"Liu H, Zhang H, Wu X, Ma D, Wu J, Wang L, et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature. 2018;563:131\u20136.","journal-title":"Nature"},{"key":"8607_CR40","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1158\/0008-5472.CAN-20-3738","volume":"81","author":"B Wei","year":"2021","unstructured":"Wei B, Xu L, Guo W, Wang Y, Wu J, Li X, et al. SHP2-mediated inhibition of DNA repair contributes to cGAS-STING activation and chemotherapeutic sensitivity in colon cancer. Cancer Res. 2021;81:3215\u201328.","journal-title":"Cancer Res"},{"key":"8607_CR41","doi-asserted-by":"publisher","first-page":"14738","DOI":"10.3390\/ijms241914738","volume":"24","author":"W Zheng","year":"2023","unstructured":"Zheng W, Chen N, Meurens F, Zheng W, Zhu J. How does cGAS avoid sensing self-DNA under normal physiological conditions? Int J Mol Sci. 2023;24:14738.","journal-title":"Int J Mol Sci"},{"key":"8607_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/gtc.12433","volume":"21","author":"R Koyama","year":"2016","unstructured":"Koyama R, Arai T, Kijima M, Sato S, Miura S, Yuasa M, et al. DNase \u03b3, DNase I and caspase-activated DNase cooperate to degrade dead cells. Genes Cells. 2016;21:1150\u201363.","journal-title":"Genes Cells"},{"key":"8607_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119278","volume":"1869","author":"R Anindya","year":"2022","unstructured":"Anindya R. Cytoplasmic DNA in cancer cells: several pathways that potentially limit DNase2 and TREX1 activities. Biochim Biophys Acta Mol Cell Res. 2022;1869:119278.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8607_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.celrep.2014.08.074","volume":"9","author":"YY Lan","year":"2014","unstructured":"Lan YY, Londo\u00f1o D, Bouley R, Rooney MS, Hacohen N. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Rep. 2014;9:180\u201392.","journal-title":"Cell Rep"},{"key":"8607_CR45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","volume":"134","author":"DB Stetson","year":"2008","unstructured":"Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008;134:587\u201398.","journal-title":"Cell"},{"key":"8607_CR46","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.molcel.2020.12.037","volume":"81","author":"L Mohr","year":"2021","unstructured":"Mohr L, Toufektchan E, von Morgen P, Chu K, Kapoor A, Maciejowski J. ER-directed TREX1 limits cGAS activation at micronuclei. Mol Cell. 2021;81:724\u201338.e9.","journal-title":"Mol Cell"},{"key":"8607_CR47","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1093\/nar\/gkq455","volume":"38","author":"M Christmann","year":"2010","unstructured":"Christmann M, Tomicic MT, Aasland D, Berdelle N, Kaina B. Three prime exonuclease I (TREX1) is Fos\/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage. Nucleic Acids Res. 2010;38:6418\u201332.","journal-title":"Nucleic Acids Res"},{"key":"8607_CR48","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1016\/j.cell.2021.08.035","volume":"184","author":"GP de Freitas Nader","year":"2021","unstructured":"de Freitas Nader GP, Ag\u00fcera-Gonzalez S, Routet F, Gratia M, Maurin M, Cancila V, et al. Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion. Cell. 2021;184:5230\u201346.e22.","journal-title":"Cell"},{"key":"8607_CR49","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2021.01.024","volume":"81","author":"W Zhou","year":"2021","unstructured":"Zhou W, Mohr L, Maciejowski J, Kranzusch PJ. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol Cell. 2021;81:739\u201355.e7.","journal-title":"Mol Cell"},{"key":"8607_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.molcel.2022.12.023","volume":"83","author":"M Ghosh","year":"2023","unstructured":"Ghosh M, Saha S, Li J, Montrose DC, Martinez LA. p53 engages the cGAS\/STING cytosolic DNA sensing pathway for tumor suppression. Mol Cell. 2023;83:266\u201380.e6.","journal-title":"Mol Cell"},{"key":"8607_CR51","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.celrep.2019.01.105","volume":"26","author":"M Gentili","year":"2019","unstructured":"Gentili M, Lahaye X, Nadalin F, Nader GFP, Lombardi EP, Herve S, et al. The N-terminal domain of cGAS determines preferential association with centromeric DNA and innate immune activation in the nucleus. Cell Rep. 2019;26:2377.","journal-title":"Cell Rep"},{"key":"8607_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-020-2750-6","volume":"587","author":"GR Pathare","year":"2020","unstructured":"Pathare GR, Decout A, Gl\u00fcck S, Cavadini S, Makasheva K, Hovius R, et al. Structural mechanism of cGAS inhibition by the nucleosome. Nature. 2020;587:668\u201372.","journal-title":"Nature"},{"key":"8607_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-020-2749-z","volume":"587","author":"B Zhao","year":"2020","unstructured":"Zhao B, Xu P, Rowlett CM, Jing T, Shinde O, Lei Y, et al. The molecular basis of tight nuclear tethering and inactivation of cGAS. Nature. 2020;587:673\u20137.","journal-title":"Nature"},{"key":"8607_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaw6421","volume":"369","author":"B Guey","year":"2020","unstructured":"Guey B, Wischnewski M, Decout A, Makasheva K, Kaynak M, Sakar MS, et al. BAF restricts cGAS on nuclear DNA to prevent innate immune activation. Science. 2020;369:823\u20138.","journal-title":"Science"},{"key":"8607_CR55","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-06889-6","volume":"625","author":"M-G Cho","year":"2024","unstructured":"Cho M-G, Kumar RJ, Lin C-C, Boyer JA, Shahir JA, Fagan-Solis K, et al. MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis. Nature. 2024;625:585\u201392.","journal-title":"Nature"},{"key":"8607_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108490","volume":"33","author":"S Cui","year":"2020","unstructured":"Cui S, Yu Q, Chu L, Cui Y, Ding M, Wang Q, et al. Nuclear cGAS functions non-canonically to enhance antiviral immunity via recruiting methyltransferase Prmt5. Cell Rep. 2020;33:108490.","journal-title":"Cell Rep"},{"key":"8607_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43001-y","volume":"14","author":"Z Zhen","year":"2023","unstructured":"Zhen Z, Chen Y, Wang H, Tang H, Zhang H, Liu H, et al. Nuclear cGAS restricts L1 retrotransposition by promoting TRIM41-mediated ORF2p ubiquitination and degradation. Nat Commun. 2023;14:8217.","journal-title":"Nat Commun"},{"key":"8607_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb8941","volume":"6","author":"H Chen","year":"2020","unstructured":"Chen H, Chen H, Zhang J, Wang Y, Simoneau A, Yang H, et al. cGAS suppresses genomic instability as a decelerator of replication forks. Sci Adv. 2020;6:eabb8941.","journal-title":"Sci Adv"},{"key":"8607_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41421-020-0162-2","volume":"6","author":"L Zhong","year":"2020","unstructured":"Zhong L, Hu M-M, Bian L-J, Liu Y, Chen Q, Shu H-B. Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis. Cell Discov. 2020;6:26.","journal-title":"Cell Discov"},{"key":"8607_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc5386","volume":"371","author":"T Li","year":"2021","unstructured":"Li T, Huang T, Du M, Chen X, Du F, Ren J, et al. Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science. 2021;371:eabc5386.","journal-title":"Science"},{"key":"8607_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10072","volume":"6","author":"S Pillai","year":"2015","unstructured":"Pillai S, Nguyen J, Johnson J, Haura E, Coppola D, Chellappan S. Tank binding kinase 1 is a centrosome-associated kinase necessary for microtubule dynamics and mitosis. Nat Commun. 2015;6:10072.","journal-title":"Nat Commun"},{"key":"8607_CR62","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","volume":"178","author":"C Zierhut","year":"2019","unstructured":"Zierhut C, Yamaguchi N, Paredes M, Luo J-D, Carroll T, Funabiki H. The cytoplasmic DNA sensor cGAS promotes mitotic cell death. Cell. 2019;178:302\u201315.e23.","journal-title":"Cell"},{"key":"8607_CR63","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1158\/0008-5472.CAN-18-1972","volume":"79","author":"DRE Ranoa","year":"2019","unstructured":"Ranoa DRE, Widau RC, Mallon S, Parekh AD, Nicolae CM, Huang X, et al. STING promotes homeostasis via regulation of cell proliferation and chromosomal stability. Cancer Res. 2019;79:1465\u201379.","journal-title":"Cancer Res"},{"key":"8607_CR64","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s12276-020-0416-y","volume":"52","author":"A Basit","year":"2020","unstructured":"Basit A, Cho M-G, Kim E-Y, Kwon D, Kang S-J, Lee J-H. The cGAS\/STING\/TBK1\/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels. Exp Mol Med. 2020;52:643\u201357.","journal-title":"Exp Mol Med"},{"key":"8607_CR65","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1101\/gad.1971610","volume":"24","author":"T Kuilman","year":"2010","unstructured":"Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev. 2010;24:2463\u201379.","journal-title":"Genes Dev"},{"key":"8607_CR66","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123:966\u201372.","journal-title":"J Clin Invest"},{"key":"8607_CR67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"T-W Kang","year":"2011","unstructured":"Kang T-W, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479:547\u201351.","journal-title":"Nature"},{"key":"8607_CR68","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ncb3586","volume":"19","author":"S Gl\u00fcck","year":"2017","unstructured":"Gl\u00fcck S, Guey B, Gulen MF, Wolter K, Kang T-W, Schmacke NA, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 2017;19:1061\u201370.","journal-title":"Nat Cell Biol"},{"key":"8607_CR69","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41586-019-0885-0","volume":"565","author":"J Nassour","year":"2019","unstructured":"Nassour J, Radford R, Correia A, Fust\u00e9 JM, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659\u201363.","journal-title":"Nature"},{"key":"8607_CR70","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/onc.2010.553","volume":"30","author":"WC Comb","year":"2011","unstructured":"Comb WC, Cogswell P, Sitcheran R, Baldwin AS. IKK-dependent, NF-\u03baB-independent control of autophagic gene expression. Oncogene. 2011;30:1727\u201332.","journal-title":"Oncogene"},{"key":"8607_CR71","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"MB Fuertes","year":"2011","unstructured":"Fuertes MB, Kacha AK, Kline J, Woo S-R, Kranz DM, Murphy KM, et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med. 2011;208:2005\u201316.","journal-title":"J Exp Med"},{"key":"8607_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay5006","volume":"12","author":"CS Bader","year":"2020","unstructured":"Bader CS, Barreras H, Lightbourn CO, Copsel SN, Wolf D, Meng J, et al. STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets. Sci Transl Med. 2020;12:eaay5006.","journal-title":"Sci Transl Med"},{"key":"8607_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9013","volume":"12","author":"W Li","year":"2020","unstructured":"Li W, Lu L, Lu J, Wang X, Yang C, Jin J, et al. cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020;12:eaay9013.","journal-title":"Sci Transl Med"},{"key":"8607_CR74","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med. 2011;208:1989\u20132003.","journal-title":"J Exp Med"},{"key":"8607_CR75","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"S-R Woo","year":"2014","unstructured":"Woo S-R, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MYK, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41:830\u201342.","journal-title":"Immunity"},{"key":"8607_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6166","volume":"5","author":"J Ahn","year":"2014","unstructured":"Ahn J, Xia T, Konno H, Konno K, Ruiz P, Barber GN. Inflammation-driven carcinogenesis is mediated through STING. Nat Commun. 2014;5:5166.","journal-title":"Nat Commun"},{"key":"8607_CR77","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41:843\u201352.","journal-title":"Immunity"},{"key":"8607_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022110597","volume":"42","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang H, Wang Y, Bramasole L, Guo K, Mourtada F, et al. DNA sensing via the cGAS\/STING pathway activates the immunoproteasome and adaptive T-cell immunity. EMBO J. 2023;42:e110597.","journal-title":"EMBO J"},{"key":"8607_CR79","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jhep.2022.03.011","volume":"77","author":"S Wang","year":"2022","unstructured":"Wang S, Wu Q, Chen T, Su R, Pan C, Qian J, et al. Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model. J Hepatol. 2022;77:467\u201378.","journal-title":"J Hepatol"},{"key":"8607_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113108","volume":"42","author":"L Lu","year":"2023","unstructured":"Lu L, Yang C, Zhou X, Wu L, Hong X, Li W, et al. STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells. Cell Rep. 2023;42:113108.","journal-title":"Cell Rep"},{"key":"8607_CR81","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.immuni.2016.04.010","volume":"44","author":"SSW Ho","year":"2016","unstructured":"Ho SSW, Zhang WYL, Tan NYJ, Khatoo M, Suter MA, Tripathi S, et al. The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells. Immunity. 2016;44:1177\u201389.","journal-title":"Immunity"},{"key":"8607_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5:3\u20138.","journal-title":"Cancer Immunol Res"},{"key":"8607_CR83","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2019.02.029","volume":"450","author":"J Pei","year":"2019","unstructured":"Pei J, Zhang Y, Luo Q, Zheng W, Li W, Zeng X, et al. STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity. Cancer Lett. 2019;450:110\u201322.","journal-title":"Cancer Lett"},{"key":"8607_CR84","doi-asserted-by":"publisher","first-page":"e007035","DOI":"10.1136\/jitc-2023-007035","volume":"11","author":"M Wang","year":"2023","unstructured":"Wang M, Huang Y, Chen M, Wang W, Wu F, Zhong T, et al. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade. J Immunother Cancer. 2023;11:e007035.","journal-title":"J Immunother Cancer"},{"key":"8607_CR85","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fonc.2020.00896","volume":"10","author":"H Cheng","year":"2020","unstructured":"Cheng H, Xu Q, Lu X, Yuan H, Li T, Zhang Y, et al. Activation of STING by cGAMP regulates MDSCs to suppress tumor metastasis via reversing epithelial-mesenchymal transition. Front Oncol. 2020;10:896.","journal-title":"Front Oncol"},{"key":"8607_CR86","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.it.2017.07.013","volume":"39","author":"KW Ng","year":"2018","unstructured":"Ng KW, Marshall EA, Bell JC, Lam WL. cGAS-STING and cancer: dichotomous roles in tumor immunity and development. Trends Immunol. 2018;39:44\u201354.","journal-title":"Trends Immunol"},{"key":"8607_CR87","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","volume":"6","author":"JM Diamond","year":"2018","unstructured":"Diamond JM, Vanpouille-Box C, Spada S, Rudqvist N-P, Chapman JR, Ueberheide BM, et al. Exosomes shuttle TREX1-sensitive IFN-stimulatory dsDNA from irradiated cancer cells to DCs. Cancer Immunol Res. 2018;6:910\u201320.","journal-title":"Cancer Immunol Res"},{"key":"8607_CR88","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.4049\/jimmunol.1601694","volume":"198","author":"Y Kitai","year":"2017","unstructured":"Kitai Y, Kawasaki T, Sueyoshi T, Kobiyama K, Ishii KJ, Zou J, et al. DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J Immunol. 2017;198:1649\u201359.","journal-title":"J Immunol"},{"key":"8607_CR89","doi-asserted-by":"crossref","unstructured":"Ma X, Chen M, Meng L. Second messenger 2\u20193\u2019-cyclic GMP-AMP (2\u20193\u2019-cGAMP): the cell autonomous and non-autonomous roles in cancer progression. Acta Pharmacol Sin. 2024;45:890\u20139.","DOI":"10.1038\/s41401-023-01210-7"},{"key":"8607_CR90","doi-asserted-by":"publisher","first-page":"e03187","DOI":"10.1128\/mBio.03187-19","volume":"11","author":"G P\u00e9pin","year":"2020","unstructured":"P\u00e9pin G, De Nardo D, Rootes CL, Ullah TR, Al-Asmari SS, Balka KR, et al. Connexin-dependent transfer of cGAMP to phagocytes modulates antiviral responses. mBio. 2020;11:e03187\u201319.","journal-title":"mBio"},{"key":"8607_CR91","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature18268","volume":"533","author":"Q Chen","year":"2016","unstructured":"Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016;533:493\u20138.","journal-title":"Nature"},{"key":"8607_CR92","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.immuni.2022.08.006","volume":"55","author":"JH Maltbaek","year":"2022","unstructured":"Maltbaek JH, Cambier S, Snyder JM, Stetson DB. ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP. Immunity. 2022;55:1799\u2013812.e4.","journal-title":"Immunity"},{"key":"8607_CR93","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molcel.2019.05.006","volume":"75","author":"C Ritchie","year":"2019","unstructured":"Ritchie C, Cordova AF, Hess GT, Bassik MC, Li L. SLC19A1 is an importer of the immunotransmitter cGAMP. Mol Cell. 2019;75:372\u201381.e5.","journal-title":"Mol Cell"},{"key":"8607_CR94","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1021\/acscentsci.1c00440","volume":"7","author":"AF Cordova","year":"2021","unstructured":"Cordova AF, Ritchie C, B\u00f6hnert V, Li L. Human SLC46A2 is the dominant cGAMP importer in extracellular cGAMP-sensing macrophages and monocytes. ACS Cent Sci. 2021;7:1073\u201388.","journal-title":"ACS Cent Sci"},{"key":"8607_CR95","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","volume":"52","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Fei M, Zhang G, Liang W-C, Lin W, Wu Y, et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. Immunity. 2020;52:357\u201373.e9.","journal-title":"Immunity"},{"key":"8607_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110880","volume":"39","author":"X Wei","year":"2022","unstructured":"Wei X, Zhang L, Yang Y, Hou Y, Xu Y, Wang Z, et al. LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity. Cell Rep. 2022;39:110880.","journal-title":"Cell Rep"},{"key":"8607_CR97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41590-021-01105-x","volume":"23","author":"AR Concepcion","year":"2022","unstructured":"Concepcion AR, Wagner LE, Zhu J, Tao AY, Yang J, Khodadadi-Jamayran A, et al. The volume-regulated anion channel LRRC8C suppresses T cell function by regulating cyclic dinucleotide transport and STING-p53 signaling. Nat Immunol. 2022;23:287\u2013302.","journal-title":"Nat Immunol"},{"key":"8607_CR98","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3389\/fimmu.2020.02090","volume":"11","author":"M Campisi","year":"2020","unstructured":"Campisi M, Sundararaman SK, Shelton SE, Knelson EH, Mahadevan NR, Yoshida R, et al. Tumor-derived cGAMP regulates activation of the vasculature. Front Immunol. 2020;11:2090.","journal-title":"Front Immunol"},{"key":"8607_CR99","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1172\/JCI125413","volume":"129","author":"H Yang","year":"2019","unstructured":"Yang H, Lee WS, Kong SJ, Kim CG, Kim JH, Chang SK, et al. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade. J Clin Invest. 2019;129:4350\u201364.","journal-title":"J Clin Invest"},{"key":"8607_CR100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo J-A, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467\u201372.","journal-title":"Nature"},{"key":"8607_CR101","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018;174:1347\u201360.","journal-title":"Cell"},{"key":"8607_CR102","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2018.07.008","volume":"49","author":"Y Hou","year":"2018","unstructured":"Hou Y, Liang H, Rao E, Zheng W, Huang X, Deng L, et al. Non-canonical NF-\u03baB antagonizes STING sensor-mediated DNA sensing in radiotherapy. Immunity. 2018;49:490\u2013503.e4.","journal-title":"Immunity"},{"key":"8607_CR103","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.immuni.2014.02.006","volume":"40","author":"J Jin","year":"2014","unstructured":"Jin J, Hu H, Li HS, Yu J, Xiao Y, Brittain GC, et al. Noncanonical NF-\u03baB pathway controls the production of type I interferons in antiviral innate immunity. Immunity. 2014;40:342\u201354.","journal-title":"Immunity"},{"key":"8607_CR104","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41388-017-0120-0","volume":"37","author":"H Konno","year":"2018","unstructured":"Konno H, Yamauchi S, Berglund A, Putney RM, Mul\u00e9 JJ, Barber GN. Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production. Oncogene. 2018;37:2037\u201351.","journal-title":"Oncogene"},{"key":"8607_CR105","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-16-1404","volume":"76","author":"T Xia","year":"2016","unstructured":"Xia T, Konno H, Barber GN. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis. Cancer Res. 2016;76:6747\u201359.","journal-title":"Cancer Res"},{"key":"8607_CR106","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","volume":"14","author":"T Xia","year":"2016","unstructured":"Xia T, Konno H, Ahn J, Barber GN. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep. 2016;14:282\u201397.","journal-title":"Cell Rep"},{"key":"8607_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00573-w","volume":"8","author":"MF Gulen","year":"2017","unstructured":"Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, et al. Signalling strength determines proapoptotic functions of STING. Nat Commun. 2017;8:427.","journal-title":"Nat Commun"},{"key":"8607_CR108","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/1541-7786.MCR-18-0504","volume":"17","author":"NMGP de Queiroz","year":"2019","unstructured":"de Queiroz NMGP, Xia T, Konno H, Barber GN. Ovarian cancer cells commonly exhibit defective STING signaling which affects sensitivity to viral oncolysis. Mol Cancer Res. 2019;17:974\u201386.","journal-title":"Mol Cancer Res"},{"key":"8607_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105514","volume":"166","author":"S-S Zou","year":"2021","unstructured":"Zou S-S, Qiao Y, Zhu S, Gao B, Yang N, Liu Y-J, et al. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: how therapy can overcome them. Pharmacol Res. 2021;166:105514.","journal-title":"Pharmacol Res"},{"key":"8607_CR110","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620:1080\u20138.","journal-title":"Nature"},{"key":"8607_CR111","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.bbadis.2015.08.011","volume":"1852","author":"D Liang","year":"2015","unstructured":"Liang D, Xiao-Feng H, Guan-Jun D, Er-Ling H, Sheng C, Ting-Ting W, et al. Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun\/CCL22 signal. Biochim Biophys Acta. 2015;1852:2494\u2013503.","journal-title":"Biochim Biophys Acta"},{"key":"8607_CR112","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41423-022-00903-z","volume":"19","author":"J Chen","year":"2022","unstructured":"Chen J, Zhao D, Zhang L, Zhang J, Xiao Y, Wu Q, et al. Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC). Cell Mol Immunol. 2022;19:1054\u201366.","journal-title":"Cell Mol Immunol"},{"key":"8607_CR113","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-15-1456","volume":"76","author":"H Lemos","year":"2016","unstructured":"Lemos H, Mohamed E, Huang L, Ou R, Pacholczyk G, Arbab AS, et al. STING promotes the growth of tumors characterized by low antigenicity via IDO activation. Cancer Res. 2016;76:2076\u201381.","journal-title":"Cancer Res"},{"key":"8607_CR114","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"8607_CR115","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.it.2020.01.003","volume":"41","author":"T Imanishi","year":"2020","unstructured":"Imanishi T, Saito T. T cell co-stimulation and functional modulation by innate signals. Trends Immunol. 2020;41:200\u201312.","journal-title":"Trends Immunol"},{"key":"8607_CR116","doi-asserted-by":"publisher","first-page":"e005151","DOI":"10.1136\/jitc-2022-005151","volume":"10","author":"H Ni","year":"2022","unstructured":"Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10:e005151.","journal-title":"J Immunother Cancer"},{"key":"8607_CR117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Dobbs N, Yang K, Yan N. Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity. 2020;53:115\u201326.e5.","journal-title":"Immunity"},{"key":"8607_CR118","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.20161674","volume":"214","author":"S Cerboni","year":"2017","unstructured":"Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M-C, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769\u201385.","journal-title":"J Exp Med"},{"key":"8607_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","volume":"610","author":"S Li","year":"2022","unstructured":"Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N, et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. 2022;610:373\u201380.","journal-title":"Nature"},{"key":"8607_CR120","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887\u201395.","journal-title":"EMBO J"},{"key":"8607_CR121","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/70932","volume":"5","author":"H Dong","year":"1999","unstructured":"Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365\u20139.","journal-title":"Nat Med"},{"key":"8607_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21:28.","journal-title":"Mol Cancer"},{"key":"8607_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2546-5","volume":"11","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Jia S, Shao C, Shi Y. Irradiation induces cancer lung metastasis through activation of the cGAS-STING-CCL5 pathway in mesenchymal stromal cells. Cell Death Dis. 2020;11:326.","journal-title":"Cell Death Dis"},{"key":"8607_CR124","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","volume":"112","author":"S-S Du","year":"2022","unstructured":"Du S-S, Chen G-W, Yang P, Chen Y-X, Hu Y, Zhao Q-Q, et al. Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation. Int J Radiat Oncol Biol Phys. 2022;112:1243\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8607_CR125","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/jcp.30135","volume":"236","author":"H Aboulkheyr Es","year":"2021","unstructured":"Aboulkheyr Es H, Bigdeli B, Zhand S, Aref AR, Thiery JP, Warkiani ME. Mesenchymal stem cells induce PD-L1 expression through the secretion of CCL5 in breast cancer cells. J Cell Physiol. 2021;236:3918\u201328.","journal-title":"J Cell Physiol"},{"key":"8607_CR126","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","volume":"9","author":"X-W Bi","year":"2016","unstructured":"Bi X-W, Wang H, Zhang W-W, Wang J-H, Liu W-J, Xia Z-J, et al. PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma. J Hematol Oncol. 2016;9:109.","journal-title":"J Hematol Oncol"},{"key":"8607_CR127","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","volume":"75","author":"J Peng","year":"2015","unstructured":"Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, et al. Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-\u03baB to foster an immunosuppressive tumor microenvironment in ovarian cancer. Cancer Res. 2015;75:5034\u201345.","journal-title":"Cancer Res"},{"key":"8607_CR128","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1038\/onc.2017.47","volume":"36","author":"A Bouillez","year":"2017","unstructured":"Bouillez A, Rajabi H, Jin C, Samur M, Tagde A, Alam M, et al. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer. Oncogene. 2017;36:4037\u201346.","journal-title":"Oncogene"},{"key":"8607_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109790","volume":"123","author":"H Cai","year":"2020","unstructured":"Cai H, Yan L, Liu N, Xu M, Cai H. IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway. Biomed Pharmacother. 2020;123:109790.","journal-title":"Biomed Pharmacother"},{"key":"8607_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"key":"8607_CR131","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/ncb1559","volume":"9","author":"X Wang","year":"2007","unstructured":"Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, et al. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol. 2007;9:470\u20138.","journal-title":"Nat Cell Biol"},{"key":"8607_CR132","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijo.2016.3500","volume":"49","author":"J Wang","year":"2016","unstructured":"Wang J, Yi S, Zhou J, Zhang Y, Guo F. The NF-\u03baB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells. Int J Oncol. 2016;49:381\u201392.","journal-title":"Int J Oncol"},{"key":"8607_CR133","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1158\/0008-5472.CAN-08-4635","volume":"69","author":"Y Xu","year":"2009","unstructured":"Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, et al. RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Cancer Res. 2009;69:3267\u201371.","journal-title":"Cancer Res"},{"key":"8607_CR134","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13046-022-02243-2","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhu S, Du Y, Xu F, Sun W, Xu Z, et al. RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion. J Exp Clin Cancer Res. 2022;41:66.","journal-title":"J Exp Clin Cancer Res"},{"key":"8607_CR135","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong C, Schubert M, Tijhuis AE, Requesens M, Roorda M, van den Brink A, et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature. 2022;607:366\u201373.","journal-title":"Nature"},{"key":"8607_CR136","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"A Marcus","year":"2018","unstructured":"Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity. 2018;49:754\u201363.e4.","journal-title":"Immunity"},{"key":"8607_CR137","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","volume":"29","author":"L Schadt","year":"2019","unstructured":"Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 2019;29:1236\u201348.e7.","journal-title":"Cell Rep"},{"key":"8607_CR138","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s43018-020-0028-4","volume":"1","author":"JA Carozza","year":"2020","unstructured":"Carozza JA, B\u00f6hnert V, Nguyen KC, Skariah G, Shaw KE, Brown JA, et al. Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity. Nat Cancer. 2020;1:184\u201396.","journal-title":"Nat Cancer"},{"key":"8607_CR139","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nchembio.1661","volume":"10","author":"L Li","year":"2014","unstructured":"Li L, Yin Q, Kuss P, Maliga Z, Mill\u00e1n JL, Wu H, et al. Hydrolysis of 2\u20193\u2019-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Nat Chem Biol. 2014;10:1043\u20138.","journal-title":"Nat Chem Biol"},{"key":"8607_CR140","doi-asserted-by":"publisher","unstructured":"Mardjuki R, Wang S, Carozza JA, Abhiraman GC, Lyu X, Li L. Identification of extracellular membrane protein ENPP3 as a major cGAMP hydrolase, cementing cGAMP\u2019s role as an immunotransmitter. bioRxiv [Preprint]. 2024. Available from https:\/\/doi.org\/10.1101\/2024.01.12.575449.","DOI":"10.1101\/2024.01.12.575449"},{"key":"8607_CR141","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.immuni.2023.10.001","volume":"56","author":"Y Hou","year":"2023","unstructured":"Hou Y, Wang Z, Liu P, Wei X, Zhang Z, Fan S, et al. SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing. Immunity. 2023;56:2492\u2013507.e10.","journal-title":"Immunity"},{"key":"8607_CR142","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/2159-8290.CD-20-0387","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J, et al. Metastasis and immune evasion from extracellular cGAMP hydrolysis. Cancer Discov. 2021;11:1212\u201327.","journal-title":"Cancer Discov"},{"key":"8607_CR143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313693120","volume":"120","author":"S Wang","year":"2023","unstructured":"Wang S, B\u00f6hnert V, Joseph AJ, Sudaryo V, Skariah G, Swinderman JT, et al. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer. Proc Natl Acad Sci USA. 2023;120:e2313693120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR144","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1777624","volume":"9","author":"J Le Naour","year":"2020","unstructured":"Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G. Trial watch: STING agonists in cancer therapy. Oncoimmunology. 2020;9:1777624.","journal-title":"Oncoimmunology"},{"key":"8607_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01247-w","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X. cGAS-STING pathway in cancer biotherapy. Mol Cancer. 2020;19:136.","journal-title":"Mol Cancer"},{"key":"8607_CR146","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","volume":"114","author":"Y Lee","year":"2009","unstructured":"Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009;114:589\u201395.","journal-title":"Blood"},{"key":"8607_CR147","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.3390\/ijms21228877","volume":"21","author":"Q Storozynsky","year":"2020","unstructured":"Storozynsky Q, Hitt MM. The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer. Int J Mol Sci. 2020;21:8877.","journal-title":"Int J Mol Sci"},{"key":"8607_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1156239","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, Hu C, Zhang W, Ruan Y, Ma Y, Chen D, et al. Advances of MnO2 nanomaterials as novel agonists for the development of cGAS-STING-mediated therapeutics. Front Immunol. 2023;14:1156239.","journal-title":"Front Immunol"},{"key":"8607_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.120412","volume":"315","author":"X Zhang","year":"2022","unstructured":"Zhang X, Liu J, Wang H. The cGAS-STING-autophagy pathway: novel perspectives in neurotoxicity induced by manganese exposure. Environ Pollut. 2022;315:120412.","journal-title":"Environ Pollut"},{"key":"8607_CR150","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020;30:966\u201379.","journal-title":"Cell Res"},{"key":"8607_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1128840","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Ruan Y, Ma Y, Chen D, Zhang T, Fan S, et al. Immunomodulatory activity of manganese dioxide nanoparticles: promising for novel vaccines and immunotherapeutics. Front Immunol. 2023;14:1128840.","journal-title":"Front Immunol"},{"key":"8607_CR152","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang C, Guan Y, Lv M, Zhang R, Guo Z, Wei X, et al. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses. Immunity. 2018;48:675\u201387.e7.","journal-title":"Immunity"},{"key":"8607_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202105783","volume":"34","author":"J Yan","year":"2022","unstructured":"Yan J, Wang G, Xie L, Tian H, Li J, Li B, et al. Engineering radiosensitizer-based metal-phenolic networks potentiate STING pathway activation for advanced radiotherapy. Adv Mater. 2022;34:e2105783.","journal-title":"Adv Mater"},{"key":"8607_CR154","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300028","volume":"12","author":"Y Gu","year":"2023","unstructured":"Gu Y, Lin S, Wu Y, Xu P, Zhu W, Wang Y, et al. Targeting STING activation by antigen-inspired MnO2 nanovaccines optimizes tumor radiotherapy. Adv Healthc Mater. 2023;12:e2300028.","journal-title":"Adv Healthc Mater"},{"key":"8607_CR155","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-016-0277-y","volume":"9","author":"W Ma","year":"2016","unstructured":"Ma W, Gilligan BM, Yuan J, Li T. Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol. 2016;9:47.","journal-title":"J Hematol Oncol"},{"key":"8607_CR156","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1073\/pnas.1621363114","volume":"114","author":"H Wang","year":"2017","unstructured":"Wang H, Hu S, Chen X, Shi H, Chen C, Sun L, et al. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proc Natl Acad Sci USA. 2017;114:1637\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR157","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1021\/acsnano.2c10352","volume":"17","author":"Z Deng","year":"2023","unstructured":"Deng Z, Xi M, Zhang C, Wu X, Li Q, Wang C, et al. Biomineralized MnO2 nanoplatforms mediated delivery of immune checkpoint inhibitors with STING pathway activation to potentiate cancer radio-immunotherapy. ACS Nano. 2023;17:4495\u2013506.","journal-title":"ACS Nano"},{"key":"8607_CR158","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax5032","volume":"6","author":"K-W Huang","year":"2020","unstructured":"Huang K-W, Hsu F-F, Qiu JT, Chern G-J, Lee Y-A, Chang C-C, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020;6:eaax5032.","journal-title":"Sci Adv"},{"key":"8607_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202210988","volume":"61","author":"Y Ling","year":"2022","unstructured":"Ling Y, Xia X, Hao L, Wang W, Zhang H, Liu L, et al. Simultaneous photoactivation of cGAS-STING pathway and pyroptosis by platinum(II) triphenylamine complexes for cancer immunotherapy. Angew Chem Int Ed Engl. 2022;61:e202210988.","journal-title":"Angew Chem Int Ed Engl"},{"key":"8607_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33301-0","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Liu Y, Xue C, Hu Y, Zhao Y, Cai K, et al. A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses. Nat Commun. 2022;13:5685.","journal-title":"Nat Commun"},{"key":"8607_CR161","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","volume":"9","author":"C Pantelidou","year":"2019","unstructured":"Pantelidou C, Sonzogni O, De Oliveria Taveira M, Mehta AK, Kothari A, Wang D, et al. PARP inhibitor efficacy depends on CD8+ T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer. Cancer Discov. 2019;9:722\u201337.","journal-title":"Cancer Discov"},{"key":"8607_CR162","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1172\/JCI130445","volume":"130","author":"L Wang","year":"2020","unstructured":"Wang L, Yang L, Wang C, Zhao W, Ju Z, Zhang W, et al. Inhibition of the ATM\/Chk2 axis promotes cGAS\/STING signaling in ARID1A-deficient tumors. J Clin Invest. 2020;130:5951\u201366.","journal-title":"J Clin Invest"},{"key":"8607_CR163","first-page":"1","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Wang B, Tu J, Liu C, Wang Y, Chen J, et al. ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I. Cell Death Dis. 2024;15:1\u201314.","journal-title":"Cell Death Dis"},{"key":"8607_CR164","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","volume":"9","author":"T Sen","year":"2019","unstructured":"Sen T, Rodriguez BL, Chen L, Corte CMD, Morikawa N, Fujimoto J, et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated t-cell activation in small cell lung cancer. Cancer Discov. 2019;9:646\u201361.","journal-title":"Cancer Discov"},{"key":"8607_CR165","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1021\/acsnano.3c01404","volume":"17","author":"Q Li","year":"2023","unstructured":"Li Q, Dong Z, Cao Z, Lei H, Wang C, Hao Y, et al. A general biomineralization strategy to synthesize autologous cancer vaccines with cGAS-STING activating capacity for postsurgical immunotherapy. ACS Nano. 2023;17:10496\u2013510.","journal-title":"ACS Nano"},{"key":"8607_CR166","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899238","volume":"37","author":"JS Riley","year":"2018","unstructured":"Riley JS, Quarato G, Cloix C, Lopez J, O\u2019Prey J, Pearson M, et al. Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J. 2018;37:e99238.","journal-title":"EMBO J"},{"key":"8607_CR167","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.scib.2023.02.027","volume":"68","author":"J-L Liang","year":"2023","unstructured":"Liang J-L, Jin X-K, Zhang S-M, Huang Q-X, Ji P, Deng X-C, et al. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Sci Bull. 2023;68:622\u201336.","journal-title":"Sci Bull"},{"key":"8607_CR168","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.1021\/acsnano.2c03509","volume":"16","author":"W Song","year":"2022","unstructured":"Song W, Song S-J, Kuang J, Yang H, Yu T, Yang F, et al. Activating innate immunity by a STING signal amplifier for local and systemic immunotherapy. ACS Nano. 2022;16:15977\u201393.","journal-title":"ACS Nano"},{"key":"8607_CR169","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007778","volume":"33","author":"X Guo","year":"2021","unstructured":"Guo X, Yang N, Ji W, Zhang H, Dong X, Zhou Z, et al. Mito-bomb: targeting mitochondria for cancer therapy. Adv Mater. 2021;33:e2007778.","journal-title":"Adv Mater"},{"key":"8607_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102830","volume":"38","author":"MD Yaqoob","year":"2022","unstructured":"Yaqoob MD, Xu L, Li C, Leong MML, Xu DD. Targeting mitochondria for cancer photodynamic therapy. Photodiagn Photodyn Ther. 2022;38:102830.","journal-title":"Photodiagn Photodyn Ther"},{"key":"8607_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01835-0","volume":"21","author":"J Liu","year":"2023","unstructured":"Liu J, Xiang J, Jin C, Ye L, Wang L, Gao Y, et al. Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression. J Nanobiotechnol. 2023;21:78.","journal-title":"J Nanobiotechnol"},{"key":"8607_CR172","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1158\/1078-0432.CCR-22-1681","volume":"29","author":"B Ruiz-Fern\u00e1ndez de C\u00f3rdoba","year":"2023","unstructured":"Ruiz-Fern\u00e1ndez de C\u00f3rdoba B, Mart\u00ednez-Monge R, Lecanda F. ENPP1 immunobiology as a therapeutic target. Clin Cancer Res. 2023;29:2184\u201393.","journal-title":"Clin Cancer Res"},{"key":"8607_CR173","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119189119","volume":"119","author":"JA Carozza","year":"2022","unstructured":"Carozza JA, Cordova AF, Brown JA, AlSaif Y, B\u00f6hnert V, Cao X, et al. ENPP1\u2019s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling. Proc Natl Acad Sci USA. 2022;119:e2119189119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8607_CR174","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.chembiol.2020.11.001","volume":"27","author":"D Cogan","year":"2020","unstructured":"Cogan D, Bakhoum SF. Re-awakening innate immune signaling in cancer: the development of highly potent ENPP1 inhibitors. Cell Chem Biol. 2020;27:1327\u20138.","journal-title":"Cell Chem Biol"},{"key":"8607_CR175","first-page":"55","volume":"48","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang H, Xu L, Ye H, Huang J, Jing X, et al. cGAMP-targeting injectable hydrogel system promotes periodontal restoration by alleviating cGAS-STING pathway activation. Bioact Mater. 2025;48:55\u201370.","journal-title":"Bioact Mater"},{"key":"8607_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410151","volume":"12","author":"L Luo","year":"2025","unstructured":"Luo L, Zhang S, Gong J, Zhang J, Xie P, Yin J, et al. 3-D sustained-release culture carrier alleviates rat intervertebral disc degeneration by targeting STING in transplanted skeletal stem cells. Adv Sci. 2025;12:e2410151.","journal-title":"Adv Sci"},{"key":"8607_CR177","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.joca.2025.02.771","volume":"33","author":"J Zheng","year":"2025","unstructured":"Zheng J, Ma Z, Liu P, Wei J, Min S, Shan Y, et al. EZH2 inhibits senescence-associated inflammation and attenuates intervertebral disc degeneration by regulating the cGAS\/STING pathway via H3K27me3. Osteoarthritis Cartilage. 2025;33:548\u201359.","journal-title":"Osteoarthritis Cartilage"},{"key":"8607_CR178","doi-asserted-by":"publisher","first-page":"805","DOI":"10.4103\/NRR.NRR-D-24-00245","volume":"20","author":"JM Izquierdo","year":"2025","unstructured":"Izquierdo JM. Mitochondria-cGAS-STING axis is a potential therapeutic target for senescence-dependent inflammaging-associated neurodegeneration. Neural Regen Res. 2025;20:805\u20137.","journal-title":"Neural Regen Res"},{"key":"8607_CR179","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1074\/jbc.M117.804005","volume":"292","author":"L Yuan","year":"2017","unstructured":"Yuan L, Mao Y, Luo W, Wu W, Xu H, Wang XL, et al. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism. J Biol Chem. 2017;292:15002\u201315.","journal-title":"J Biol Chem"},{"key":"8607_CR180","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2020.02.002","volume":"52","author":"LS Huang","year":"2020","unstructured":"Huang LS, Hong Z, Wu W, Xiong S, Zhong M, Gao X, et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity. 2020;52:475\u201386.e5.","journal-title":"Immunity"},{"key":"8607_CR181","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuron.2022.10.028","volume":"111","author":"X Wang","year":"2023","unstructured":"Wang X, Yang C, Wang X, Miao J, Chen W, Zhou Y, et al. Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFN\u03b3-cGAS-STING axis. Neuron. 2023;111:236\u201355.e7.","journal-title":"Neuron"},{"key":"8607_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08620-4","volume":"10","author":"L Lama","year":"2019","unstructured":"Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, et al. Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression. Nat Commun. 2019;10:2261.","journal-title":"Nat Commun"},{"key":"8607_CR183","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ccell.2018.03.027","volume":"33","author":"J Ahn","year":"2018","unstructured":"Ahn J, Xia T, Rabasa Capote A, Betancourt D, Barber GN. Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells. Cancer Cell. 2018;33:862\u201373.e5.","journal-title":"Cancer Cell"},{"key":"8607_CR184","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.4049\/jimmunol.1401869","volume":"193","author":"J Klarquist","year":"2014","unstructured":"Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM. STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. J Immunol. 2014;193:6124\u201334.","journal-title":"J Immunol"},{"key":"8607_CR185","doi-asserted-by":"publisher","first-page":"e002195","DOI":"10.1136\/jitc-2020-002195","volume":"9","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Yang H, Kim WR, Lee YS, Lee WS, Kong SJ, et al. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer. J Immunother Cancer. 2021;9:e002195.","journal-title":"J Immunother Cancer"},{"key":"8607_CR186","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2020.07.007","volume":"27","author":"JA Carozza","year":"2020","unstructured":"Carozza JA, Brown JA, B\u00f6hnert V, Fernandez D, AlSaif Y, Mardjuki RE, et al. Structure-aided development of small-molecule inhibitors of ENPP1, the extracellular phosphodiesterase of the immunotransmitter cGAMP. Cell Chem Biol. 2020;27:1347\u201358.e5.","journal-title":"Cell Chem Biol"},{"key":"8607_CR187","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1158\/2159-8290.CD-21-0932","volume":"12","author":"B Ruiz-Fern\u00e1ndez de C\u00f3rdoba","year":"2022","unstructured":"Ruiz-Fern\u00e1ndez de C\u00f3rdoba B, Moreno H, Valencia K, Perurena N, Ruedas P, Walle T, et al. Tumor ENPP1 (CD203a)\/haptoglobin axis exploits myeloid-derived suppressor cells to promote post-radiotherapy local recurrence in breast cancer. Cancer Discov. 2022;12:1356\u201377.","journal-title":"Cancer Discov"},{"key":"8607_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105549","volume":"119","author":"M Gangar","year":"2022","unstructured":"Gangar M, Goyal S, Raykar D, Khurana P, Martis AM, Goswami A, et al. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy. Bioorg Chem. 2022;119:105549.","journal-title":"Bioorg Chem"},{"key":"8607_CR189","doi-asserted-by":"crossref","unstructured":"Kim S, Ali I, Yu A, Lee SW, Park SY, Choi JH, et al. Abstract LBA009: Orally available ENPP1 inhibitor, TXN10128, restores STING activation in tumor microenvironment and confers anti-tumor responses in combination with immune checkpoint blockade. Mol Cancer Ther. 2021;20:LBA009.","DOI":"10.1158\/1535-7163.TARG-21-LBA009"},{"key":"8607_CR190","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1593809","volume":"8","author":"H Zhang","year":"2019","unstructured":"Zhang H, Vijayan D, Li X-Y, Robson SC, Geetha N, Teng MWL, et al. The role of NK cells and CD39 in the immunological control of tumor metastases. Oncoimmunology. 2019;8:e1593809.","journal-title":"Oncoimmunology"},{"key":"8607_CR191","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1158\/1538-7445.AM2023-577","volume":"83","author":"X Qin","year":"2023","unstructured":"Qin X, Li Y, Sun S, Li X, Peng Z, Kong D, et al. Abstract 577: ENPP1 inhibitor ZX-8177 in combination with chemotherapy or radiation exhibits synergistic anti-tumor effects via STING-mediated response. Cancer Res. 2023;83:577.","journal-title":"Cancer Res"},{"key":"8607_CR192","doi-asserted-by":"crossref","unstructured":"Csiki I, Dong A, Tuan BY, John E, O\u2019Toole L, Seppa J, et al. First-in-human experience using RBS2418, an oral ENPP1 inhibitor within an expanded access protocol in combination with pembrolizumab in a patient with metastatic adrenal cancer. J Clin Oncol. 2022;40:e14550.","DOI":"10.1200\/JCO.2022.40.16_suppl.e14550"},{"key":"8607_CR193","doi-asserted-by":"crossref","unstructured":"Weston AS, Thode T, Shah M, Seiz A, Northrup J, Kasibhatla S, et al. Abstract CT161: First-in-human study of ENPP1 inhibitor, SR-8541A, for the treatment of solid tumors. Cancer Res. 2024;84:CT161.","DOI":"10.1158\/1538-7445.AM2024-CT161"},{"key":"8607_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1070492","volume":"14","author":"X Chu","year":"2023","unstructured":"Chu X, Baek D-S, Li W, Shyp T, Mooney B, Hines MG, et al. Human antibodies targeting ENPP1 as candidate therapeutics for cancers. Front Immunol. 2023;14:1070492.","journal-title":"Front Immunol"},{"key":"8607_CR195","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","volume":"29","author":"F Meric-Bernstam","year":"2023","unstructured":"Meric-Bernstam F, Sweis RF, Kasper S, Hamid O, Bhatia S, Dummer R, et al. Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study. Clin Cancer Res. 2023;29:110\u201321.","journal-title":"Clin Cancer Res"},{"key":"8607_CR196","doi-asserted-by":"publisher","first-page":"S1446","DOI":"10.1016\/j.annonc.2020.10.559","volume":"31","author":"DP Zandberg","year":"2020","unstructured":"Zandberg DP, Ferris R, Laux D, Mehra R, Nabell L, Kaczmar J, et al. A phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: preliminary safety, efficacy and PK\/PD results. Ann Oncol. 2020;31:S1446\u20137.","journal-title":"Ann Oncol"},{"key":"8607_CR197","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","volume":"31","author":"KJ Harrington","year":"2025","unstructured":"Harrington KJ, Champiat S, Brody JD, Cho BC, Romano E, Golan T, et al. Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas. Clin Cancer Res. 2025;31:3400\u201311.","journal-title":"Clin Cancer Res"},{"key":"8607_CR198","doi-asserted-by":"publisher","first-page":"S683","DOI":"10.1016\/j.annonc.2020.08.1087","volume":"31","author":"KJ Harrington","year":"2020","unstructured":"Harrington KJ, William WN, Khilnani A, Algazi AP. Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma. Ann Oncol. 2020;31:S683.","journal-title":"Ann Oncol"},{"key":"8607_CR199","doi-asserted-by":"publisher","unstructured":"Montesinos P, Al-Ali H, Alonso-Dominguez JM, Jentzsch M, Jongen-Lavrencic M, Martelli MP, et al. A first-in-clinic phase 1 study of GSK3745417 STING agonist in relapsed\/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer Res. 2023;83:CT124. https:\/\/doi.org\/10.1158\/1538-7445.AM2023-CT124.","DOI":"10.1158\/1538-7445.AM2023-CT124"},{"key":"8607_CR200","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","volume":"29","author":"JJ Luke","year":"2023","unstructured":"Luke JJ, Piha-Paul SA, Medina T, Verschraegen CF, Varterasian M, Brennan AM, et al. Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clin Cancer Res. 2023;29:2435\u201344.","journal-title":"Clin Cancer Res"},{"key":"8607_CR201","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1158\/2767-9764.CRC-25-0566","volume":"5","author":"BT Cooper","year":"2025","unstructured":"Cooper BT, Iams WT, Page DB, Yuan Y, Gerber NK, Luke JJ, et al. Phase 1b study of dazostinag plus pembrolizumab after hypofractionated radiotherapy in patients with select advanced solid tumors. Cancer Res Commun. 2025;5:2249\u201363.","journal-title":"Cancer Res Commun"},{"key":"8607_CR202","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/2767-9764.CRC-21-0161","volume":"2","author":"E Carideo Cunniff","year":"2022","unstructured":"Carideo Cunniff E, Sato Y, Mai D, Appleman VA, Iwasaki S, Kolev V, et al. TAK-676: a novel stimulator of interferon genes (STING) agonist promoting durable IFN-dependent antitumor immunity in preclinical studies. Cancer Res Commun. 2022;2:489\u2013502.","journal-title":"Cancer Res Commun"},{"key":"8607_CR203","doi-asserted-by":"publisher","first-page":"e011572","DOI":"10.1136\/jitc-2025-011572","volume":"13","author":"J Jacoby","year":"2025","unstructured":"Jacoby J, Mahalingam D, Alistar A, Garmey E, Kazmi S, Mooneyham T, et al. Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies. J Immunother Cancer. 2025;13:e011572.","journal-title":"J Immunother Cancer"},{"key":"8607_CR204","first-page":"A527","volume":"9","author":"J Wang","year":"2021","unstructured":"Wang J, Falchook G, Nabhan S, Kulkarni M, Sandy P, Dosunmu O, et al. Trial of Snx281, a systemically delivered small molecule sting agonist, in solid tumors and lymphomas. J Immunother Cancer. 2021;9:A527.","journal-title":"J Immunother Cancer"},{"key":"8607_CR205","doi-asserted-by":"crossref","unstructured":"Foldi J, Piha-Paul SA, Villaruz LC, McArthur HL, Olson M, Jonathan E, et al. A phase 1 dose-escalation and expansion study of an intratumorally administered dual STING agonist (ONM-501) alone and in combination with cemiplimab in patients with advanced solid tumors and lymphomas. J Clin Oncol. 2024;42:TPS2693.","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2693"},{"key":"8607_CR206","first-page":"S626","volume":"34","author":"E Calvo","year":"2023","unstructured":"Calvo E, Garralda E, Alonso G, Gambardella V, Parkes EE, Thompson J, et al. Phase I, first-in-human trial evaluating the STING agonist BI 1387446 alone and in combination with ezabenlimab in solid tumors. Ann Oncol. 2023;34:S626.","journal-title":"Ann Oncol"},{"key":"8607_CR207","doi-asserted-by":"crossref","unstructured":"Diamond JR, Henry JT, Falchook GS, Olszanski AJ, Singh H, Leonard EJ, et al. First-in-human study of TAK-500, a novel STING agonist immune stimulating antibody conjugate (ISAC), alone and in combination with pembrolizumab in patients with select advanced solid tumors. Cancer Res. 2022;82:CT249.","DOI":"10.1158\/1538-7445.AM2022-CT249"},{"key":"8607_CR208","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/14796694.2024.2441107","volume":"21","author":"K Harrington","year":"2025","unstructured":"Harrington K, Kitano S, Gambardella V, Parkes EE, Moreno I, Alonso G, et al. Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors. Future Oncol. 2025;21:195\u2013200.","journal-title":"Future Oncol"},{"key":"8607_CR209","doi-asserted-by":"crossref","unstructured":"Janku F, Strauss J, Karim R, Olszanski AJ, Luke JJ, Leach K, et al. A phase Ia\/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors. J Clin Oncol. 2020;38:TPS3162.","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS3162"},{"key":"8607_CR210","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-24-2449","volume":"31","author":"RA Bukhalid","year":"2025","unstructured":"Bukhalid RA, Duvall JR, Lancaster K, Catcott KC, Cetinbas NM, Monnell T, et al. XMT-2056, a HER2-directed STING agonist antibody-drug conjugate, induces innate antitumor immune responses by acting on cancer cells and tumor-resident immune cells. Clin Cancer Res. 2025;31:1766\u201382.","journal-title":"Clin Cancer Res"},{"key":"8607_CR211","doi-asserted-by":"publisher","first-page":"e010511","DOI":"10.1136\/jitc-2024-010511","volume":"13","author":"JJ Luke","year":"2025","unstructured":"Luke JJ, Pinato DJ, Juric D, Lorusso P, Hosein PJ, Desai AM, et al. Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors. J Immunother Cancer. 2025;13:e010511.","journal-title":"J Immunother Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08607-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08607-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:01:57Z","timestamp":1774990917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08607-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":211,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8607"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08607-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}